Ricky D Shafer
Examiner (ID: 1251)
Most Active Art Unit | 2872 |
Art Unit(s) | 2507, 2872 |
Total Applications | 2439 |
Issued Applications | 1744 |
Pending Applications | 164 |
Abandoned Applications | 501 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
09/662751 | Uses of synthetic peptides corresponding to telopeptide sequences of cross-linked type 1 collagen metabolites | Sep 14, 2000 | Abandoned |
Array
(
[id] => 1230447
[patent_doc_number] => 06692752
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-17
[patent_title] => 'Methods of treating human females susceptible to HSV infection'
[patent_app_type] => B1
[patent_app_number] => 09/661926
[patent_app_country] => US
[patent_app_date] => 2000-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10145
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/692/06692752.pdf
[firstpage_image] =>[orig_patent_app_number] => 09661926
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/661926 | Methods of treating human females susceptible to HSV infection | Sep 13, 2000 | Issued |
Array
(
[id] => 1368293
[patent_doc_number] => RE038046
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2003-03-25
[patent_title] => 'Enhancement of the cellular immune response'
[patent_app_type] => E1
[patent_app_number] => 09/644662
[patent_app_country] => US
[patent_app_date] => 2000-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3387
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/038/RE038046.pdf
[firstpage_image] =>[orig_patent_app_number] => 09644662
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/644662 | Enhancement of the cellular immune response | Aug 24, 2000 | Issued |
Array
(
[id] => 4269416
[patent_doc_number] => 06280687
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-28
[patent_title] => 'Diagnostic method for detection of periodontitis or peri-implantitis'
[patent_app_type] => 1
[patent_app_number] => 9/642380
[patent_app_country] => US
[patent_app_date] => 2000-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 16164
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/280/06280687.pdf
[firstpage_image] =>[orig_patent_app_number] => 642380
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/642380 | Diagnostic method for detection of periodontitis or peri-implantitis | Aug 20, 2000 | Issued |
Array
(
[id] => 1514265
[patent_doc_number] => 06420125
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-16
[patent_title] => 'Assaying fragments of collagen in body fluids'
[patent_app_type] => B1
[patent_app_number] => 09/641756
[patent_app_country] => US
[patent_app_date] => 2000-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 9488
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/420/06420125.pdf
[firstpage_image] =>[orig_patent_app_number] => 09641756
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/641756 | Assaying fragments of collagen in body fluids | Aug 20, 2000 | Issued |
Array
(
[id] => 1255860
[patent_doc_number] => 06667151
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-23
[patent_title] => 'Vaccines and immunotherapeutics derived from the human immunodeficiency virus (HIV) trans-activator of transcription protein for the treatment and prevention of HIV disease'
[patent_app_type] => B1
[patent_app_number] => 09/636057
[patent_app_country] => US
[patent_app_date] => 2000-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7536
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/667/06667151.pdf
[firstpage_image] =>[orig_patent_app_number] => 09636057
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/636057 | Vaccines and immunotherapeutics derived from the human immunodeficiency virus (HIV) trans-activator of transcription protein for the treatment and prevention of HIV disease | Aug 9, 2000 | Issued |
Array
(
[id] => 4345313
[patent_doc_number] => 06290968
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-18
[patent_title] => 'Rotavirus reassortant vaccine'
[patent_app_type] => 1
[patent_app_number] => 9/628289
[patent_app_country] => US
[patent_app_date] => 2000-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10490
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/290/06290968.pdf
[firstpage_image] =>[orig_patent_app_number] => 628289
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/628289 | Rotavirus reassortant vaccine | Jul 27, 2000 | Issued |
Array
(
[id] => 1371562
[patent_doc_number] => 06566513
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-20
[patent_title] => 'Lentivirus from the group of immunodeficiency viruses of drill monkeys (Mandrillus leucophaeus) and their use'
[patent_app_type] => B1
[patent_app_number] => 09/625972
[patent_app_country] => US
[patent_app_date] => 2000-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12800
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/566/06566513.pdf
[firstpage_image] =>[orig_patent_app_number] => 09625972
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/625972 | Lentivirus from the group of immunodeficiency viruses of drill monkeys (Mandrillus leucophaeus) and their use | Jul 25, 2000 | Issued |
Array
(
[id] => 1391159
[patent_doc_number] => 06548635
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-15
[patent_title] => 'Retrovirus from the HIV type O and its use (MVP-2901/94)'
[patent_app_type] => B1
[patent_app_number] => 09/610271
[patent_app_country] => US
[patent_app_date] => 2000-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7145
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/548/06548635.pdf
[firstpage_image] =>[orig_patent_app_number] => 09610271
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/610271 | Retrovirus from the HIV type O and its use (MVP-2901/94) | Jul 5, 2000 | Issued |
Array
(
[id] => 4244688
[patent_doc_number] => 06221580
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-24
[patent_title] => 'Anti-idiotypic and its uses in diagnosis and therapy in HIV-related disease'
[patent_app_type] => 1
[patent_app_number] => 9/610316
[patent_app_country] => US
[patent_app_date] => 2000-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 18
[patent_no_of_words] => 12680
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/221/06221580.pdf
[firstpage_image] =>[orig_patent_app_number] => 610316
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/610316 | Anti-idiotypic and its uses in diagnosis and therapy in HIV-related disease | Jul 4, 2000 | Issued |
Array
(
[id] => 1309947
[patent_doc_number] => 06610304
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-26
[patent_title] => 'Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus'
[patent_app_type] => B1
[patent_app_number] => 09/607726
[patent_app_country] => US
[patent_app_date] => 2000-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2616
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/610/06610304.pdf
[firstpage_image] =>[orig_patent_app_number] => 09607726
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/607726 | Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus | Jun 29, 2000 | Issued |
Array
(
[id] => 1473888
[patent_doc_number] => 06387614
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-14
[patent_title] => 'Methods for using redox liposome biosensors'
[patent_app_type] => B1
[patent_app_number] => 09/608788
[patent_app_country] => US
[patent_app_date] => 2000-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 11850
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/387/06387614.pdf
[firstpage_image] =>[orig_patent_app_number] => 09608788
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/608788 | Methods for using redox liposome biosensors | Jun 29, 2000 | Issued |
Array
(
[id] => 1535271
[patent_doc_number] => 06337073
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-08
[patent_title] => 'Intranasal yellow fever vaccination'
[patent_app_type] => B1
[patent_app_number] => 09/581218
[patent_app_country] => US
[patent_app_date] => 2000-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3200
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/337/06337073.pdf
[firstpage_image] =>[orig_patent_app_number] => 09581218
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/581218 | Intranasal yellow fever vaccination | Jun 21, 2000 | Issued |
Array
(
[id] => 1576786
[patent_doc_number] => 06447778
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-10
[patent_title] => 'Peptide compositions for the treatment of HIV infection'
[patent_app_type] => B1
[patent_app_number] => 09/599286
[patent_app_country] => US
[patent_app_date] => 2000-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 48
[patent_no_of_words] => 33542
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/447/06447778.pdf
[firstpage_image] =>[orig_patent_app_number] => 09599286
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/599286 | Peptide compositions for the treatment of HIV infection | Jun 21, 2000 | Issued |
Array
(
[id] => 1445933
[patent_doc_number] => 06368602
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-09
[patent_title] => 'Mucosal immunization against hepatitis A virus (HAV) through rectal administration of HAV vaccine'
[patent_app_type] => B1
[patent_app_number] => 09/596060
[patent_app_country] => US
[patent_app_date] => 2000-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2025
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/368/06368602.pdf
[firstpage_image] =>[orig_patent_app_number] => 09596060
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/596060 | Mucosal immunization against hepatitis A virus (HAV) through rectal administration of HAV vaccine | Jun 15, 2000 | Issued |
Array
(
[id] => 4362980
[patent_doc_number] => 06287565
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-11
[patent_title] => 'Modified HGP-30 heteroconjugates, compositions and methods of use'
[patent_app_type] => 1
[patent_app_number] => 9/594845
[patent_app_country] => US
[patent_app_date] => 2000-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16972
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/287/06287565.pdf
[firstpage_image] =>[orig_patent_app_number] => 594845
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/594845 | Modified HGP-30 heteroconjugates, compositions and methods of use | Jun 14, 2000 | Issued |
Array
(
[id] => 1170483
[patent_doc_number] => 06749856
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-06-15
[patent_title] => 'Mucosal cytotoxic T lymphocyte responses'
[patent_app_type] => B1
[patent_app_number] => 09/508552
[patent_app_country] => US
[patent_app_date] => 2000-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 0
[patent_no_of_words] => 18417
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/749/06749856.pdf
[firstpage_image] =>[orig_patent_app_number] => 09508552
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/508552 | Mucosal cytotoxic T lymphocyte responses | Jun 11, 2000 | Issued |
Array
(
[id] => 1040734
[patent_doc_number] => 06870032
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-22
[patent_title] => 'Assay for the diagnosis of flaviviral infection using antibodies with high affinity for NS1 protein of flavivirus in hexameric form'
[patent_app_type] => utility
[patent_app_number] => 09/980839
[patent_app_country] => US
[patent_app_date] => 2000-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9015
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/870/06870032.pdf
[firstpage_image] =>[orig_patent_app_number] => 09980839
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/980839 | Assay for the diagnosis of flaviviral infection using antibodies with high affinity for NS1 protein of flavivirus in hexameric form | Jun 8, 2000 | Issued |
Array
(
[id] => 4290121
[patent_doc_number] => 06268472
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-31
[patent_title] => 'Modified HGP-30 peptides, conjugates, compositions and methods of use'
[patent_app_type] => 1
[patent_app_number] => 9/589768
[patent_app_country] => US
[patent_app_date] => 2000-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14894
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/268/06268472.pdf
[firstpage_image] =>[orig_patent_app_number] => 589768
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/589768 | Modified HGP-30 peptides, conjugates, compositions and methods of use | Jun 8, 2000 | Issued |
Array
(
[id] => 4263035
[patent_doc_number] => 06258945
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-10
[patent_title] => 'HIV-1P-17 peptide fragments, compositions containing and methods for producing and using same'
[patent_app_type] => 1
[patent_app_number] => 9/588751
[patent_app_country] => US
[patent_app_date] => 2000-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15503
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/258/06258945.pdf
[firstpage_image] =>[orig_patent_app_number] => 588751
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/588751 | HIV-1P-17 peptide fragments, compositions containing and methods for producing and using same | Jun 6, 2000 | Issued |